Exam 4: Cancer 2 Flashcards
cancer critical genes
genes whose alterations frequently contribute to cancer formation
2 classes of cancer critical genes?
- oncogenes
- tumor suppressor genes
Oncogenes
normally promote cell proliferation which help to control the cell cycle
- include gain of function
Gain of function (result)
mutation into an overactive form lead to cancer in oncogenes ⇒ heterozygosity
what are dominant effects of oncogenes?
(overactivity mutation) 1 mutation takes over fxn
- Normal forms ⇒ proto-oncogenes
- Mutated forms ⇒ oncogenes
Tumor suppressor genes
normally suppress cell proliferation
- have a loss of function mutation
Loss of function
mutation that leads to cancer in tumor suppressor genes (2 in same gene) forming non functioning proteins
- These mutations are generally recessive
recessive
effects are seen when both copies are mutated
how can conversions to proto-oncogenes occur? (4)
- Deletion or point mutation
- Regulatory mutation
- Gene amplification
- Chromosome rearrangement
Deletion or point mutation activity
hyperactive protein made in normal amounts
Regulatory mutation activity
normal protein greatly overproduced
Gene amplification activity
normal protein greatly overproduced
Chromosome rearrangement
nearby regulatory DNA sequence causes normal protein to be overproduced or fusion to actively transcribed gene produces hyperactive fusion protein
what mutation usually occurs with Epidermal growth factor (EGF) receptor?
usually is an RTK activated by binding of a growth factor but results in a constitutively active form when mutated
when is the RTK active with a mutation?
Active in the absence of the ligand ⇒ ligand usually binds and dimerizes the RTK’s to cross phosphorylation and activate the intracellular domain
- When normally active it makes the signal decrease but when mutated the ligand binding domain is mutated so that it is not there but it has some affinity to form a dimer still
Truncated receptor
triggers intracellular signaling in the absence of growth factor
Fusion Abl
tyrosine kinase that stimulates overproduction of hemopoietic precursor cells when hyperactive ⇒ turns on cell division signaling all the time
what causes chronic myelogenous leukemia (CML)
Breakpoint of the philadelphia chromosome
- a portion of 9 and a portion of 22 which creates a fusion of 2 genes as well as in frame in the protein coding sequences
- This means you get fusion proteins and each part is coming from different original chromosome
- hyperactive version of Abl called Bcr-Abl
Burkitt’s lymphoma
cancer of lymphocytes caused by the breakpoint of the chromosome 8 and 14 rearrangement
- Results in abnormal activation of the Myc gene under the control of B lymphocyte regulatory sequences
- one protein is from 14 called immunoglobulin gene enhancer and the other from chromosome 8 has Myc
what is special about the enhancer in Burkitt’s Lymphoma?
The enhancer (chromosome 14) is upstream of Myc so the protein coding sequence is normal but the promoter is much stronger
- This occurs in the lymphocyte cells which drives expression of Myc to cause cell division
can we identify oncogenes? How?
Yes by dominant transforming effects
- Tumor cells ⇒ isolate DNA ⇒ fragments ⇒ transfect into normal cells ⇒ isolate DNA from the transformed cells ⇒ identify a mutation (oncogene) ⇒ multilayer of transformed cells
what was the first oncogene identified?
Ras
- find a plasmid DNA mutation with an abnormal sequence => cells still have normal proto-oncogenes and have 2 good copies but the plasmid they uptook has the dominant effect
can we use the same method for tumor suppressor cells as oncogenes?
No because it is recessive and needs 2 mutations
- Only works when you lose the function of both proteins but adding broken proteins won’t do anything
Ras
monomeric GTPase, upstream of the MAP kinase cascade
- Ras oncogene has point mutations which make a hyperactive protein (Mutated in 30% of all human cancers)
Retinoblastoma
a rare type of cancer caused by loss of Rb gene
2 forms of retinoblastoma
- Hereditary (both eyes) form
- Non hereditary (one eye) form